Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/23295
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Omari, T. | - |
dc.contributor.author | Benninga, M. | - |
dc.contributor.author | Sansom, L. | - |
dc.contributor.author | Butler, R. | - |
dc.contributor.author | Dent, J. | - |
dc.contributor.author | Davidson, G. | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Journal of Pediatrics, 2006; 149(4):468-474 | - |
dc.identifier.issn | 0022-3476 | - |
dc.identifier.issn | 1097-6833 | - |
dc.identifier.uri | http://hdl.handle.net/2440/23295 | - |
dc.description.abstract | <h4>Objective</h4>To evaluate the effect of baclofen, a gamma-amino-butyric-acid B receptor agonist that inhibits transient lower esophageal sphincter relaxation (TLESR), on the rates of TLESR, gastroesophageal reflux (GER), and gastric emptying (GE) in children with GER disease.<h4>Study design</h4>The efficacy of 0.5 mg/kg baclofen was evaluated in a randomized, double-blinded, placebo-controlled trial in 30 children. Patients were intubated with a manometric/pH assembly and given 250 mL of cow's milk. Esophageal motility and pH were then measured for 2 hours (control period). Baclofen or placebo was then administered, and 1 hour later 250 mL of milk was given again and measurements performed for another 2 hours (test period). The GE rate was measured by the (13)C octanoate breath test.<h4>Results</h4>Baclofen significantly reduced the incidence of TLESR (mean, 7.3 +/- 1.5 vs 3.6 +/- 1.2 TLESR/2 hours; P < .05) and acid GER (mean 4.2 +/- 0.7 vs 1.7 +/- 1.0 TLESR + GER/2 hours; P < .05) during the test period compared with the control period. Baclofen significantly accelerated the GE rate (median [interquartile range], GE(t1/2), 61 minutes [39, 81 minutes] vs 114 minutes [67, 170 minutes]; P < .05). Baclofen had no effect on the swallowing rate, pattern of esophageal peristalsis, or lower esophageal sphincter pressure.<h4>Conclusions</h4>Baclofen reduces GER in children by inhibiting the triggering of TLESR. Baclofen also accelerates GE. | - |
dc.language.iso | en | - |
dc.publisher | Mosby Inc | - |
dc.source.uri | http://dx.doi.org/10.1016/j.jpeds.2006.05.029 | - |
dc.subject | Humans | - |
dc.subject | Gastroesophageal Reflux | - |
dc.subject | Baclofen | - |
dc.subject | GABA Agonists | - |
dc.subject | Double-Blind Method | - |
dc.subject | Gastrointestinal Motility | - |
dc.subject | Adolescent | - |
dc.subject | Child | - |
dc.subject | Child, Preschool | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.title | Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: A randomized controlled trial | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.jpeds.2006.05.029 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Omari, T. [0000-0001-5108-7378] | - |
Appears in Collections: | Aurora harvest 6 Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.